0000905148-18-000758.txt : 20180906 0000905148-18-000758.hdr.sgml : 20180906 20180906142127 ACCESSION NUMBER: 0000905148-18-000758 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180905 FILED AS OF DATE: 20180906 DATE AS OF CHANGE: 20180906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weissman James B CENTRAL INDEX KEY: 0001598480 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36281 FILM NUMBER: 181057318 MAIL ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc CENTRAL INDEX KEY: 0001399529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617 621 8097 MAIL ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 form4.xml X0306 4 2018-09-05 0001399529 Dicerna Pharmaceuticals Inc DRNA 0001598480 Weissman James B C/O DICERNA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 true Chief Business Officer Common Stock 2018-09-05 4 M 0 2301 3.42 A 26781 D Common Stock 2018-09-05 4 S 0 2301 17.5 D 24480 D Employee Stock Option (Right to Buy) 3.42 2018-09-05 4 M 0 2301 0 D 2023-09-24 Common Stock 2301 47699 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 5, 2018. The vesting of this option is subject to achievement of pre-established performance goals. As of the transaction date, 50% of the option (representing 30,000 shares) was vested. /s/ James B. Weissman 2018-09-06